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Abstract: Chordoma is a slowly growing and invasive bone tumor with a tendency to metastasize locally in advanced stages. It is
essential to discover new therapeutics that target genes involved in the metastasis of chordoma. Epithelial-mesenchymal transition
(EMT) might robustly influence the metastasis of a tumor bulk. To our knowledge, this is the first time to show that EMT might have
a role in chordoma metastasis. In this study, we aim to investigate the possible role of Twist, a key player transcription factor of EMT,
in chordoma metastasis. The TWIST gene was silenced by short hairpins in chordoma cell line MUG-Chor1 and effects on metastasis
were investigated by wound healing/gap closure and invasion assays. Twist-silenced MUG-Chor1 cells were found to be less migratory
and less invasive when compared to the negative control. This study indicates that Twist might have a role in metastatic chordoma cells.
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1. Introduction
Chordoma, an aggressive and locally invasive bone
neoplasm, accounts for 1%–4% of all primary bone tumors,
affecting 0.1/100,000 people in a year. It is considered
to be the second most malignant tumor of the spine
(McMaster et al., 2001). Although it is known as a lowgrade tumor, chordoma tends to relapse and metastasize
locally (Yang et al., 2009), being nonselective to tissues
and organs such as the lungs, bones, liver, soft tissues,
lymph nodes, and skin. Rare events of metastasis into the
subcutaneous tissue, muscle, heart, pleura, spleen, kidney,
bladder, pancreas, and brain have also been reported
(Bergh et al., 2000; McPherson et al., 2006; Vergara et al.,
2008). Various factors like local relapse, increased tumor
size, necrosis, and exposure to high dose radiation may
indicate the metastatic prognosis of chordoma (Chambers
and Schwinn, 1979; Markwalder et al., 1979; McPherson et
al., 2006). A study done by Bergh et al. showed that local
recurrence is related significantly with a greater risk of
metastasis and tumor-related death (Bergh et al., 2000). In
addition, there is not a clear relationship between age, sex,
and origin of the tumor with metastasis (McPherson et al.,
2006).
Metastasis is a combination of events that occur during
carcinogenesis (Eccles and Welch, 2007). Cancer cells evolve
into a mesenchymal state from an epithelial state to become
aggressive and metastatic and this process is regulated by
* Correspondence: esra.aydemir81@gmail.com

epithelial to mesenchymal transition (EMT) (Thiery, 2003;
Huber et al., 2005). EMT is a process where cells lose their
polarity and become more motile. As reported extensively
by several studies, E-cadherin expression is downregulated
as an initial step of EMT (Thiery, 2002; Zhou et al.,
2004; Bates and Mercurio, 2005). E-cadherin is the key
component of cell-cell adhesion junctions and is necessary
for the formation of epithelia in the embryo. It eventually
maintains epithelial homeostasis in adults. During
development and carcinogenesis, E-cadherin is lost at sites
of EMT. Eventually, tumor cells become invasive in vitro
and loss of E-cadherin causes the transition of adenoma
to carcinoma in in vivo models (Thiery, 2002). One of the
factors that affect the downregulation of E-CADHERIN
expression is the transcription factor TWIST. Studies done
by Yang et al. and Cheng et al. demonstrated that Twist is
primarily overexpressed in metastatic cancers (Yang et al.,
2006; Cheng et al., 2008). When it is downregulated, tumor
cells evade intravasation, a process in which metastatic
cells enter into blood circulation to travel to other sites
of the body to find new locations (Yang et al., 2006). In
addition to its role in organogenesis, recent studies show
that Twist is an essential player in triggering metastasis in
numerous kinds of tumors like breast cancer, hepatocellular
carcinoma (HCC), prostate cancer, and gastric cancer
(Chen and Behringer, 1995; Yang et al., 2004; Matsuo et al.,
2009; Yang et al., 2007).
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A recent study showed that, other than Brachyury,
another embryonic transcription factor like Twist
might have a role in the tumorigenesis of chordoma
(Vanderheijden, 2014). Therefore, we conducted the
present study to investigate the possible role of Twist in
cell migration of chordoma cells and its role in metastasis.
2. Materials and methods
2.1. Cell cultures
The MUG-Chor1 cell line was provided by the Chordoma
Foundation (Durham, NC, USA). Cells were cultured
as described by Rinner et al. (2012) in a special culture
medium of IMDM/RPMI (4:1) supplemented with 10%
FBS and 1% antibiotics (GIBCO, USA) in flasks covered
with 1% gelatin. Cells were incubated in a humidified
chamber at 37 °C in 5% CO2.
2.2. Viral particles and gene silencing
MUG-Chor1 cells were transfected with short hairpin
lentiviral particles of TWIST (sc-38604-V, Santa Cruz
Biotechnology, USA), Control-A shRNA (sc-108080,
Santa Cruz Biotechnology), and copGFP Control (sc108084, Santa Cruz Biotechnology) as instructed by
the manufacturer. In brief, cells were seeded to 12-well
culture plates at 80% confluency and incubated with
culture medium containing 5 µg/m: polybrene (sc-134220,
Santa Cruz Biotechnology) for 6 h. Lentiviral particles,
at preoptimized MOI values, were added to the medium
and cells infected with the viral particles were incubated
for 24 h. The culture medium was renewed with complete
medium containing 1 µg/mL puromycin dihydrochloride
(sc-108071, Sigma Aldrich, USA). Puromycin-resistant
colonies were selected over 2 months due to slow growth
of MUG-Chor1 cells upon viral infection (nearly 5 days of
doubling time). Over 2 months of selection period a stable
cell line was generated and verified by gene and protein
quantifications.
2.3. Gene expression/protein quantification
The changes in gene expression were measured with
qPCR. Cells were collected, total RNA was isolated by the
NucleoSpin RNA isolation kit (Macherey Nagel, USA),
and cDNAs were synthesized by the QuantiTect Reverse
Transcription Kit (205313, QIAGEN, USA) as instructed
by the manufacturers. Real-time qPCR was conducted
with TaqMan Fast Universal PCR Master Mix (4352042,
Thermo Scientific, USA) with the TaqMan probe
against TWIST (Hs01675818_s1, Thermo Scientific).
Normalization was done against GAPDH and relative foldchanges were calculated by the 2–ΔΔCt method. Results were
analyzed with the CFX96 Touch Real-Time PCR Detection
System (Bio-Rad, USA) and CFX Manager Software (V.
3.0, Bio-Rad).
Twist suppression was also confirmed by protein
analysis. Briefly, the cell pellet was resuspended in
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RIPA buffer (R0278, Sigma, USA) containing protease
and phosphatase inhibitor (78430, Thermo Scientific)
at a volume according to the size of the pellet. Protein
quantitation was done by BCA Bradford assay (23227,
Thermo Scientific). Twist protein was measured with
ELISA assay (E3531Hu, BT Laboratories, China) as
described in the manufacturer’s protocol. Absorbance
was measured with an ELx800 96-well microplate reader
(MTX Lab Systems, USA) and results were normalized to
GAPDH.
The effect of Twist silencing on proliferation was
observed by comparison of cell counts over 5 days. To do
this, Mug-shCtrl cells and Mug-shTwist cells were seeded
onto 48-well plates as 10 × 103 cells/well. The quantity of
formazan, which is considered to be directly proportional
to the number of viable cells, was measured by recording
changes in absorbance at 490 nm using a plate-reading
spectrophotometer for 5 consecutive days. Calculations
were made accordingly.
2.4. Scratch assay
MUG-Chor1 cells, silenced against TWIST (shTwist)
and a negative control (shCtrl, i.e. no gene knockdown),
were seeded into 6-well plates at 1× 105 cells/well. After
attachment, cells were scraped with a 100-µL sterile
pipette tip for wound induction. Detached cells were
removed and the serum concentration was reduced to
2%. Cells were monitored and images were taken from
three predetermined sites of the scratch under an inverted
microscope (ZEISS Axio Vert.A1, Zeiss, Germany) every
day until the gap of the control cells was completely
covered. Scratch images were evaluated by the ImageJ
Mitobo plugin (ImageJ Software, NIH, USA). The scratch
assay was repeated three times and average values were
calculated.
2.5. Gap closure assay
Gap closure assay was performed using the Radius 24well cell migration assay (CBA-125, Cell Biolabs, USA)
according to the manufacturer’s protocol. Briefly, culture
wells were treated with pretreatment solution. Then cells
were seeded and incubated overnight for attachment. The
next day, culture medium was removed and wells were
treated with medium containing gel removal solution.
Wells were rinsed with fresh culture medium twice and
cultured with 2% FBS containing culture medium. Images
of three wells for each group were taken under an inverted
microscope every day until the gap of the negative control
group was covered completely. Gap closure averages
were calculated from the results of three independent
experiment sets.
2.6. Invasion assay
A combination of two different invasion assay kits was
used to determine the invasion capabilities of chordoma
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cells upon Twist silencing. First cells were seeded onto
Matrigel-coated inserts (354480, Corning BioCoat
Matrigel Invasion Chamber, Corning, USA) and the
protocol was used as suggested by the manufacturer. For
an internal control, control inserts (354578, Corning,
USA, not provided by the kit) were used. Matrigel-coated
inserts and control inserts were placed in a 24-well plate.
Serum-free medium (IMDM/RPMI 4:1, 1% PSA) was
added to each insert and the plate was incubated at room
temperature for 1 h. Cells, in preoptimized numbers,
were seeded into insert wells with serum-free medium
and complete medium was added to the lower chamber.
The plate was incubated for 48 h. Following 2 days of
incubation, the interior of the insert was cleaned with a
wet cotton swab and the remaining cells were stained with
Giemsa stain (similar to Dif Quick stain to enhance the
visibility of the cells, which is not provided but required in
the protocol). Images from five different spots were taken
under an invert microscope. Invasion values (Invasive
Index) were calculated by comparing the invaded cells of
the Matrigel insert to the control insert (without Matrigel).
Compared to the control insert, 7% of shTwist cells passed
through the Matrigel and 35% of shControl cells passed

through the Matrigel.
2.7. Statistical analysis and image processing
Experiments were completed in three biological replicates
with three technical triplicates in each experiment and
statistical analysis was done by one-way ANOVA with
Dunnett’s posttest using GraphPad Prism 5 (GraphPad
Software, USA). A single asterisk indicates that P < 0.05.
Graphics were exported from GraphPad Prism’s graphic
generator. Cell counting, gap closure, and scratch assay
analyses were done using ImageJ (National Institute of
Health, USA) and the ImageJ Mitobo plugin.
3. Results
3.1. Gene expression analysis and protein quantitation
assays
Following transfection with viral particles, gene expression
and protein analyses were applied to confirm the silencing
for the TWIST gene. As illustrated in Figure 1A, TWIST
expression was knocked down in virus-infected MUGChor1 cells represented as Mug-shTwist compared to
unsilenced (Mug-shCtrl). As for protein analysis (Figure
1B), it was found that Twist protein amount was decreased

Figure 1. A) Relative Twist, Snail, and Slug gene expression levels were normalized to GAPDH. Triple asterisks indicate P < 0.001. B)
Relative Twist protein levels were normalized to GAPDH. Triple asterisks indicate P < 0.001. Error bars represent standard deviation.
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to 35% in Mug-shTwist cells compared to Mug-shCtrl
cells. The effect of Twist silencing on proliferation rate was
measured and no significant changes were obtained when
compared to the Mug-shCtrl cells (Supplementary Figure 1).
3.2. Wound healing assay (scratch assay)
Migratory ability of Twist-silenced cells was analyzed
through scratch assay. As can be seen in Figure 2A, the
control group closed the scratched area at the end of 5 days
while it was not closed thoroughly in Twist-silenced MUGChor1 cells. The percentage closure rate is represented in
Figure 2B. Around 40% of the area was covered by shTwist
cells while the control cells were covered by almost 90%.

3.3. Gap closure assay
To observe the migratory ability of Twist-silenced MUGChor1 cells, gap closure assay was also applied. Images in
Figure 3A illustrate that control MUG-Chor1 cells almost
closed the gap, unlike Twist-silenced MUG-Chor1 cells, at
the end of the 5th day. Figure 3B shows that 50% of the
area was closed by the shTwist cells while 90% of the area
was covered by control cells.
3.4. Invasion assay
To indicate the effect of silencing on invasiveness of MUGChor1 cells, invasion assay was carried out and the results
in Figure 4A show that control group invaded the Matrigel

Figure 2. A)Wound healing assay. B) Graphical representation of wound healing percentages. Single asterisk indicates P < 0.05 and
double asterisks indicate P < 0.01. Error bars represent standard deviation.
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membrane more than Twist-silenced cells under the same
conditions. The percentage rates of invasion of both cell
types are indicated in Figure 4B. Only 7.85% of Twistsilenced cells passed through the Matrigel membrane
while 34.5% of the control group invaded.
4. Discussion
Most cancer-related deaths result from metastasis due to
the spread of cancerous cells to other parts of the body,
allowing the formation of new cancer sites. Like in all
other cancer types, metastasis is a challenge in chordoma
patients. In our study, a chordoma cell line, MUG-Chor1,

established by Rinner et al. (2012), was used as a model
to investigate possible target genes on the metastatic
pathway. Known for its association with metastasis (Yang
et al., 2004), Twist, as the key regulator of EMT, was
targeted to decrease the migration and invasion capability
of chordoma.
Silencing of EMT was carried out by knocking down
TWIST. Premade shRNA lentiviral particles were used
to knock down TWIST, and confirmations of silencing
were performed by gene expression analysis and protein
quantification. Twist-silenced MUG-Chor1 cells were
found to be less migratory, as demonstrated by wound

Figure 3. A) Gap closure assay. B) Graphical representation of gap closure assay. Single asterisk indicates P < 0.05 and double asterisks
indicate P < 0.01. Error bars represent standard deviation.
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Figure 4. A) Comparison of invasiveness between Twist-silenced (left) and control (right) MUG-Chor1 cells (10× magnification).
B) Graphical representation of the invasive index (invasiveness compared to the control insert) of shTwist and shControl cells. Single
asterisk indicates P < 0.05 and double asterisks indicate P < 0.01. Error bars represent standard deviation.

healing, gap closure, and invasion assays, compared to
control cells. These results show that silencing of the
TWIST gene also results in reducing not only migration
but also invasion, as proposed in many studies (Kwok et
al., 2005; Vesuna et al., 2008; Croset et al., 2014; Liu et
al., 2014). Despite its slow growing behavior, chordoma
is considered one of the malignant tumors of bone. Twist
expression might be one of the factors to cause this.
Depending on the type of chordoma cases, the
expressions of EMT markers vary. A case study done by
Karamchandani et al. (2013) revealed that an aggressive
type of chordoma strongly expresses the markers of EMT
including vimentin, N-cadherin, Slug, and Twist. The highly
proliferative features of this type of tumor are associated
with the presence of expression of these markers. In our
study we also knocked down the expression of other EMT
markers including SNAIL and SLUG (Yang et al., 2009);
however, the effect on migration capacity did not change
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significantly (data not shown) as happened in TWIST.
Some studies suggested that knockdown of TWIST
inhibits cancer progression and metastasis, and increased
TWIST expression shows enhanced migratory/invasive
profiles (Fu et al., 2011; Hong et al., 2011) A previous study
showed that knock down of TBX2 primarily inhibited the
expression of the Twist gene (Du et al., 2017). There is a high
degree of homology between T-box transcription factor Tbx2
and the DNA-binding domain of Brachyury (Abrahams et al.,
2010), which is known as a prognostic marker of chordoma
(Oakley et al., 2008) Wang et al. showed that TBX2 stimulates
EMT and invasion of normal as well as malignant breast
epithelial cells (Wang et al., 2012). Silencing of TWIST might
trigger metastasis in chordoma cells based on coexpression of
TBX2 and TWIST. Therefore, we conclude that Twist might
be a significant marker and a potential target to decrease the
metastatic ability of chordoma. Suppression of TWIST might
be used against metastatic chordoma.
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Supplementary Figure 1. Comparison of proliferation
(represented as relative absorbance value comparison) between
Twist-silenced and control MUG-Chor1 cells. No significant
change was observed. Error bars represent standard deviation.

1

